secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001558370-22-017810
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Azenta reports Q4 FY2022 revenue flat YoY at $138M; authorizes $1.5B buyback, guides FY2023 revenue growth ~30%
--------------------------------------------------------------------------------

- Q4 revenue $138M (flat YoY); organic growth ex-COVID 12%; GAAP EPS from cont. ops ($0.07); non-GAAP $0.16.
- Full year FY2022 revenue $555M (+8% YoY); organic growth ex-COVID 17%; GAAP EPS ($0.15); non-GAAP $0.51.
- Board authorized $1.5B share repurchase; plans at least $1B in next year including $500M accelerated share repurchase.
- Completed acquisition of B Medical Systems for ~$422M cash on Oct 3, 2022; cash post-acquisition ~$1.9B.
- Q1 FY2023 revenue guidance $175-$190M; non-GAAP EPS $0.08-$0.16; full year revenue growth ~30%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837022017810/0001558370-22-017810-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837022017810/azta-20221111x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-017810

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer